MRF-Logo2019-Horizontal-RGB
Karen’s Question about GSK drugs
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Karen’s Question about GSK drugs

› Forums › General Melanoma Community › Karen’s Question about GSK drugs

  • Post
    • April 9, 2013 at 2:48 pm
    mrf
    Keymaster

      I have been on the road a lot and am a bit behind on posts with MPIP.  Karen, thank you for flagging your post about the new GSK drugs.

      I have been on the road a lot and am a bit behind on posts with MPIP.  Karen, thank you for flagging your post about the new GSK drugs.

      GSK has two drugs for melanoma–one is a BRAF inhibitor like Zelboraf (vemurafenib).  The other blocks the next step down in the MAP kinase pathway–MEK.  The data is complete on these drugs and the FDA is currently reviewing the data.  They have announced June 3 as the PDUFA date on these drugs, or the date by which the FDA response to the application will be made.  Sometimes the PDUFA date is pushed back, as happened with Yervoy (ipi) but this is rather unusual.  More likely the June 3 date will hold, or something will be announced early.

      The BRAF drug, dabrafenib, will only be available to people whose tumor has the BRAF mutation.  The MEK inhibitor, trametenib, will likely be used for people who are BRAF wild type but have the NRAS mutation, and may be used more broadly than that.

      The best thing about this is that with an approved MEK inhibitor doctors can more readily prescribe the BRAF and MEK drugs on combination.  The data is clear that this is a better approach than a BRAF inhibitor alone.

      Since GSK did not apply for approval of the combination it is not clear if payers (insurance companies) will cover the cost of the combination.  This will all need to be worked out, and might be an opportunity for the patient voice to be heard.

      By the way, I am in Denver for our bi-annual in-person board meeting.  If you have anything you would like me to convey to our board please send me a note at [email protected].  We meet this afternoon and tomorrow morning.

      Tim–MRF

       

       

    Viewing 8 reply threads
    • Replies
        • April 10, 2013 at 1:08 am
        NYKaren
        Participant
          Tim, thanks so much for the reply.
          I’m looking forward to both drugs being approved, and the insurance coverage questions should prove interesting.
          Karen
          • April 10, 2013 at 1:08 am
          NYKaren
          Participant
            Tim, thanks so much for the reply.
            I’m looking forward to both drugs being approved, and the insurance coverage questions should prove interesting.
            Karen
            • April 10, 2013 at 1:08 am
            NYKaren
            Participant
              Tim, thanks so much for the reply.
              I’m looking forward to both drugs being approved, and the insurance coverage questions should prove interesting.
              Karen
              • April 12, 2013 at 11:38 am
              Owl
              Participant

                Dear Tim,

                thank you for the explanation. Most of the people here are surely very excited about the approval of these drugs and especially ways to combine both drugs. We live in Germany and hope that the the MEK inhibitor will be approved in Europe as well and the combination will be possible as well. My husband is on Zelboraf almost 4 months now.

                One more question, how do you define a "approved MEK inhibitor doctors". Are these doctors that have been involved in the combination trial?

                Thanks again,

                Jenny

                • April 12, 2013 at 11:38 am
                Owl
                Participant

                  Dear Tim,

                  thank you for the explanation. Most of the people here are surely very excited about the approval of these drugs and especially ways to combine both drugs. We live in Germany and hope that the the MEK inhibitor will be approved in Europe as well and the combination will be possible as well. My husband is on Zelboraf almost 4 months now.

                  One more question, how do you define a "approved MEK inhibitor doctors". Are these doctors that have been involved in the combination trial?

                  Thanks again,

                  Jenny

                    • April 12, 2013 at 11:43 am
                    POW
                    Participant

                      Hi, Jenny-

                      There is no such thing as an "approved MEK inhibitor doctor". Perhaps inserting a comma between the two phrases in the sentence would clarify the meaning. Like this: …'with an approved MEK inhibitor, doctors can…'

                      • April 12, 2013 at 11:43 am
                      POW
                      Participant

                        Hi, Jenny-

                        There is no such thing as an "approved MEK inhibitor doctor". Perhaps inserting a comma between the two phrases in the sentence would clarify the meaning. Like this: …'with an approved MEK inhibitor, doctors can…'

                        • April 12, 2013 at 11:43 am
                        POW
                        Participant

                          Hi, Jenny-

                          There is no such thing as an "approved MEK inhibitor doctor". Perhaps inserting a comma between the two phrases in the sentence would clarify the meaning. Like this: …'with an approved MEK inhibitor, doctors can…'

                        • April 12, 2013 at 11:38 am
                        Owl
                        Participant

                          Dear Tim,

                          thank you for the explanation. Most of the people here are surely very excited about the approval of these drugs and especially ways to combine both drugs. We live in Germany and hope that the the MEK inhibitor will be approved in Europe as well and the combination will be possible as well. My husband is on Zelboraf almost 4 months now.

                          One more question, how do you define a "approved MEK inhibitor doctors". Are these doctors that have been involved in the combination trial?

                          Thanks again,

                          Jenny

                          • April 12, 2013 at 4:28 pm
                          mrsmarilyn
                          Participant

                            Hello, Thank you for the excellent update!  We are awaiting these drugs-to treat brain mets!  Timing is critical – as always in a rush for time.

                            Thanks again- I will share with the family.

                            All the best

                            MrsMarilyn

                            (sister of Gary stage IV for 11 years)

                            • April 12, 2013 at 4:28 pm
                            mrsmarilyn
                            Participant

                              Hello, Thank you for the excellent update!  We are awaiting these drugs-to treat brain mets!  Timing is critical – as always in a rush for time.

                              Thanks again- I will share with the family.

                              All the best

                              MrsMarilyn

                              (sister of Gary stage IV for 11 years)

                              • April 12, 2013 at 4:28 pm
                              mrsmarilyn
                              Participant

                                Hello, Thank you for the excellent update!  We are awaiting these drugs-to treat brain mets!  Timing is critical – as always in a rush for time.

                                Thanks again- I will share with the family.

                                All the best

                                MrsMarilyn

                                (sister of Gary stage IV for 11 years)

                            Viewing 8 reply threads
                            • You must be logged in to reply to this topic.
                            About the MRF Patient Forum

                            The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

                            The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

                            Popular Topics